Role of EGF inhibitors in the treatment of recurrent or metastatic squamous cell head and neck cancer

por Lorch, Jochen H
Publicado 2009

A Robust Method for Perfusable Microvascular Network Formation In Vitro

por Wan, Zhengpeng, Zhong, Amy X., Zhang, Shun, Pavlou, Georgios, Coughlin, Mark F., Shelton, Sarah E., Nguyen, Huu Tuan, Lorch, Jochen H., Barbie, David A., Kamm, Roger D.
Publicado 2022

Association of Programmed Death 1 Protein Ligand (PD-L1) Expression With Prognosis in Merkel Cell Carcinoma

por Hanna, Glenn J., Kacew, Alec J., Tanguturi, Anusha R., Grote, Hans J., Vergara, Victoria, Brunkhorst, Beatrice, Rabinowits, Guilherme, Thakuria, Manisha, LeBoeuf, Nicole R., Ihling, Christian, DeCaprio, James A., Lorch, Jochen H.
Publicado 2020

Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer

por Sridharan, Vishwajith, Margalit, Danielle N, Lynch, Stephanie A, Severgnini, Mariano, Zhou, Jun, Chau, Nicole G, Rabinowits, Guilherme, Lorch, Jochen H, Hammerman, Peter S, Hodi, F Stephen, Haddad, Robert I, Tishler, Roy B, Schoenfeld, Jonathan D
Publicado 2016

Hospitalization rates and 30-day all-cause mortality among head and neck cancer patients and survivors with COVID-19

por Hanna, Glenn J., Rettig, Eleni M., Park, Jong C., Varvares, Mark A., Lorch, Jochen H., Margalit, Danielle N., Schoenfeld, Jonathan D., Tishler, Roy B., Goguen, Laura A., Annino, Donald J., Haddad, Robert I., Uppaluri, Ravindra
Publicado 2021

Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial

por Kaufman, Howard L., Russell, Jeffery S., Hamid, Omid, Bhatia, Shailender, Terheyden, Patrick, D’Angelo, Sandra P., Shih, Kent C., Lebbé, Céleste, Milella, Michele, Brownell, Isaac, Lewis, Karl D., Lorch, Jochen H., von Heydebreck, Anja, Hennessy, Meliessa, Nghiem, Paul
Publicado 2018

The Impact of Hashimoto Thyroiditis on Thyroid Nodule Cytology and Risk of Thyroid Cancer

por Silva de Morais, Nathalie, Stuart, Jessica, Guan, Haixia, Wang, Zhihong, Cibas, Edmund S, Frates, Mary C, Benson, Carol B, Cho, Nancy L, Nehs, Mathew A, Alexander, Caroline A, Marqusee, Ellen, Kim, Mathew I, Lorch, Jochen H, Barletta, Justine A, Angell, Trevor E, Alexander, Erik K
Publicado 2019

SUN-LB75 The Anti-Tumor Activity of the Selective Ret Inhibitor Selpercatinib (LOXO-292) in Medullary Thyroid Cancer Is Independent of the Specific RET Mutation

por Cabanillas, Maria E, Wirth, Lori J, Sherman, Eric J, Drilon, Alexander, Solomon, Benjamin, Robinson, Bruce G, Lorch, Jochen H, McCoach, Caroline, Patel, Jyoti, Leboulleux, Sophie, Worden, Francis, Owonikoko, Taofeek K, Brose, Marcia S, Taylor, Matthew H, Subbiah, Vivek, Rothenberg, S Michael, Huang, Xin, Zhu, Edward, French, Pearl P, Shah, Manisha H
Publicado 2020

Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck

por Hanna, Glenn J., O'Neill, Anne, Shin, Kee-Young, Wong, Kristine, Jo, Vickie Y., Quinn, Charles T., Cutler, Jennifer M., Flynn, Michelle, Lizotte, Patrick H., Annino, Donald J., Goguen, Laura A., Kass, Jason I., Rettig, Eleni M., Sethi, Rosh K.V., Lorch, Jochen H., Schoenfeld, Jonathan D., Margalit, Danielle N., Tishler, Roy B., Everett, Peter C., Desai, Anupam M., Cavanaugh, Megan E., Paweletz, Cloud P., Egloff, Ann Marie, Uppaluri, Ravindra, Haddad, Robert I.
Publicado 2022